Stéphane Orlowski

7.1k total citations · 1 hit paper
74 papers, 5.9k citations indexed

About

Stéphane Orlowski is a scholar working on Molecular Biology, Biotechnology and Oncology. According to data from OpenAlex, Stéphane Orlowski has authored 74 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 25 papers in Biotechnology and 24 papers in Oncology. Recurrent topics in Stéphane Orlowski's work include Microbial Inactivation Methods (25 papers), Drug Transport and Resistance Mechanisms (24 papers) and Toxin Mechanisms and Immunotoxins (15 papers). Stéphane Orlowski is often cited by papers focused on Microbial Inactivation Methods (25 papers), Drug Transport and Resistance Mechanisms (24 papers) and Toxin Mechanisms and Immunotoxins (15 papers). Stéphane Orlowski collaborates with scholars based in France, United States and Denmark. Stéphane Orlowski's co-authors include Lluis M. Mir, Jean Belehradek, Claude Paoletti, Manuel Garrigos, Bruno Poddevin, Philippe Champeil, C. Domenge, Alexia Garrigues, Omar Tounekti and Alexandre E. Escargueil and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Stéphane Orlowski

70 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses

1991 500 citations Lluis M. Mir, Stéphane Orlowski et al. European Journal of Cancer and Clinical Oncology profile →

Peers

Countries citing papers authored by Stéphane Orlowski

Since Specialization

Citations

This map shows the geographic impact of Stéphane Orlowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Orlowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Orlowski more than expected).

Fields of papers citing papers by Stéphane Orlowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Orlowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Orlowski. The network helps show where Stéphane Orlowski may publish in the future.

Co-authorship network of co-authors of Stéphane Orlowski

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Orlowski. A scholar is included among the top collaborators of Stéphane Orlowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Orlowski. Stéphane Orlowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In silico analysis of the binding of anthelmintics to Caenorhabditis elegans P-glycoprotein 1 2016 ·International Journal for Parasitology Drugs and Drug Resistance ·(unknown), Stéphane Orlowski, Roger K. Prichard, (unknown), François André, Anne Lespine	25
2	Specific Cellular Incorporation of a Pyrene-Labelled Cholesterol: Lipoprotein-Mediated Delivery toward Ordered Intracellular Membranes 2015 ·PLoS ONE ·Gérald Gaibelet, Sophie Allart, François Tercé, Vincent Azalbert, Justine Bertrand‐Michel, Safouane M. Hamdi, Xavier Collet, Stéphane Orlowski	13
3	P-glycoprotein and ‘lipid rafts’: some ambiguous mutual relationships (floating on them, building them or meeting them by chance?) 2006 ·Cellular and Molecular Life Sciences ·Stéphane Orlowski, Stéphane Martin, Alexandre E. Escargueil	102
4	Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3) 2005 ·Chemico-Biological Interactions ·Anne Lespine, Jacques Dupuy, Stéphane Orlowski, Tünde Nagy, Hristos Glavinas, Péter Krajcsi, (unknown)	91
5	In vitro increase of the fluid-phase endocytosis induced by pulsed radiofrequency electromagnetic fields: importance of the electric field component 2004 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), (unknown), Mihaela G. Moisescu, Stéphane Orlowski, Philippe Lévêque, Lluis M. Mir	34
6	Treatment of Multiple Spontaneous Breast Tumors in Mice Using Electrochemotherapy 2003 ·Humana Press eBooks ·Stéphane Orlowski, Lluis M. Mir	1
7	Treatment of Spontaneous Soft Tissue Sarcomas in Cat 2003 ·Humana Press eBooks ·Stéphane Orlowski, Lluis M. Mir	0
8	The Basis of Electrochemotherapy 2003 ·Humana Press eBooks ·Lluis M. Mir, Stéphane Orlowski	36
9	A High-Throughput Screening Microplate Test for the Interaction of Drugs with P-Glycoprotein 2002 ·Analytical Biochemistry ·Alexia Garrigues, (unknown), Stéphane Orlowski, Éric Ezan	61
10	Characterization of Two Pharmacophores on the Multidrug Transporter P-Glycoprotein 2002 ·Molecular Pharmacology ·Alexia Garrigues, Nicolas Loiseau, Marcel Delaforge, Jacques Ferté, Manuel Garrigos, François André, Stéphane Orlowski	86
11	Structure-Activity Relationships of Cyclotetrapeptides: Interaction of Tentoxin Derivatives with Three Membrane Proteins 2001 ·Advances in experimental medicine and biology ·Nicolas Loiseau, Marcel Delaforge, (unknown), François André, Alexia Garrigues, Stéphane Orlowski, (unknown)	1
12	Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy 1998 ·British Journal of Cancer ·LM Mir, (unknown), Gregor Serša, Justin Teissié, C. Domenge, Damijan Miklavčič, (unknown), Stéphane Orlowski, Reintgen Ds, Z Rudolf, (unknown), R. A. Gilbert, Marie‐Pierre Rols, Jean Belehradek, J.M. Bachaud, Ronald C. DeConti, Borut Štabuc, Maja Čemažar, P Coninx, Richard Heller	356
13	Electrochemotherapy on liver tumours in rabbits 1998 ·British Journal of Cancer ·(unknown), Stéphane Orlowski, (unknown), (unknown), Radan Džodić, P Ardouin, C Bognel, Jean Belehradek, J. N. Munck, LM Mir	96
14	Bleomycin: Revival of an old drug 1996 ·General Pharmacology The Vascular System ·Lluis M. Mir, Omar Tounekti, Stéphane Orlowski	181
15	Strontium binding to sarcoplasmic reticulum Ca²⁺‐ATPase 1993 ·FEBS Letters ·Stéphane Orlowski, (unknown)	13
16	Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial 1993 ·Cancer ·(unknown), C. Domenge, B Luboïnski, Stéphane Orlowski, Jean Belehradek, Lluis M. Mir	371
17	Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. 1992 ·PubMed ·LM Mir, Stéphane Orlowski, Bruno Poddevin, (unknown)	87
18	Electrochemotherapy of spontaneous mammary tumours in mice 1991 ·European Journal of Cancer and Clinical Oncology ·Jean Belehradek, Stéphane Orlowski, Bruno Poddevin, Claude Paoletti, Lluis M. Mir	138
19	Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture 1991 ·Biochemical Pharmacology ·Bruno Poddevin, Stéphane Orlowski, Jean Belehradek, Lluis M. Mir	182
20	Mechanism of inhibition of the calcium-magnesium ATPase by nonylphenol 1990 ·Biochemistry ·Francesco Michelangeli, Stéphane Orlowski, Philippe Champeil, J. Malcolm East, (unknown)	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact